Thanks to Kemper Senior Solutions, a line of life and health insurance products underwritten by Reserve National Insurance Company, for granting permission to re-publish this article.
Colonoscpies are one of the most effective cancer prevention tools, yet many people avoid them, either because the preparatory procedures are unpleasant or they fear the test will be painful (it isn't). In the U.S., about 51,000 deaths are attributed to colon cancer each year.
A new colonoscopy option, PillCam, travels through the digestive system over the course of several hours, wirelessly transmitting images to an external data recorder. The maker, Covidien, is seeking broader approval. If approved, people who are not at high risk will be permitted to go about their nomal days while the PillCam works its way through their bodies.